Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Tumor, Adult”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01705548
What this trial is testing

Hypofractionated Stereotactic Radiosurgery in Treating Patients With Large Brain Metastasis

Who this might be right for
Metastatic Malignant Neoplasm to BrainUnspecified Adult Solid Tumor, Protocol Specific
Emory University 24
Early research (Phase 1)Study completedNCT00731276
What this trial is testing

Irinotecan in Treating Asian Patients With Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Centre, Singapore 18
Early research (Phase 1)Study completedNCT00831896
What this trial is testing

Phase I Study of TAK-701 in Adult Patients With Advanced Nonhematological Malignancies

Who this might be right for
Advanced Solid Tumors
Millennium Pharmaceuticals, Inc. 27
Early research (Phase 1)Ended earlyNCT01299415
What this trial is testing

Safety and Pharmacokinetics of ASA404 When Given Together With Fluvoxamine, a Selective Serotonin Receptor Reuptake Inhibitor and CYP1A2 Inhibitor

Who this might be right for
Solid Tumors
Novartis Pharmaceuticals 17
Early research (Phase 1)Looking for participantsNCT07050459
What this trial is testing

A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Locally Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd. 220
Early research (Phase 1)Ended earlyNCT02608125
What this trial is testing

A Dose Escalation Study in Solid Tumors and a Dose Expansion Study of PRN1371 in Adult Patients With Metastatic Urothelial Carcinoma

Who this might be right for
Solid TumorsMetastatic Urothelial Carcinoma & Renal Pelvis & Ureter
Principia Biopharma, a Sanofi Company 45
Early research (Phase 1)Study completedNCT00356980
What this trial is testing

TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Institutes of Health Clinical Center (CC) 60
Early research (Phase 1)Study completedNCT00002677
What this trial is testing

Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors

Who this might be right for
Prostate CancerUnspecified Adult Solid Tumor, Protocol Specific
University of Maryland, Baltimore 24
Large-scale testing (Phase 3)UnknownNCT00020865
What this trial is testing

Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia

Who this might be right for
Fever, Sweats, and Hot FlashesInfectionLeukemia+3 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT03215511
What this trial is testing

Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer

Who this might be right for
Solid Tumors Harboring NTRK Fusion
Bayer 81
Testing effectiveness (Phase 2)Active Not RecruitingNCT04243499
What this trial is testing

First-in-Human Study of ICT01 in Patients With Advanced Cancer

Who this might be right for
Solid Tumor, AdultHematopoietic/Lymphoid Cancer
ImCheck Therapeutics, an Ipsen company 293
Early research (Phase 1)WithdrawnNCT00072228
What this trial is testing

Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Daiichi Pharmaceuticals
Early research (Phase 1)Active Not RecruitingNCT06337084
What this trial is testing

Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors

Who this might be right for
Solid Tumor, AdultBladder CancerUrothelial Carcinoma+6 more
Monopar Therapeutics 12
Early research (Phase 1)Study completedNCT00485719
What this trial is testing

Study of the Safety and Pharmacokinetics of XL765 (SAR245409) in Adults With Solid Tumors

Who this might be right for
Cancer
Sanofi 83
Early research (Phase 1)Study completedNCT00049400
What this trial is testing

S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
SWOG Cancer Research Network 78
Early research (Phase 1)UnknownNCT00005611
What this trial is testing

BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
H. Lee Moffitt Cancer Center and Research Institute
Testing effectiveness (Phase 2)Looking for participantsNCT06244771
What this trial is testing

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Who this might be right for
Advanced Solid Tumors With KRAS G12C MutationsSolid Tumor, AdultUnresectable Solid Tumor+5 more
Frontier Medicines Corporation 403
Testing effectiveness (Phase 2)Active Not RecruitingNCT06334432
What this trial is testing

Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorHER2-negative Breast CancerMetastatic Castration-resistant Prostate Cancer (mCRPC)+2 more
Nuvation Bio Inc. 466
Early research (Phase 1)Ended earlyNCT05814536
What this trial is testing

IDH1 Inhibitor AB-218 in Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid Tumor

Who this might be right for
Cholangiocarcinoma With IDH1 MutationSolid Tumors With IDH1 Mutation
AnHeart Therapeutics Inc. 9
Early research (Phase 1)Study completedNCT00085904
What this trial is testing

Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or Lymphomas

Who this might be right for
Solid Tumor CancerLymphoma
GlaxoSmithKline 12
Next Page